Vascular Solutions (VASC) Tops Q1 EPS by 2c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/21/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- Far-left party wins Berlin election, pledging to nationalise housing
- Cybercrime feud erupts on dark web as notorious group claims hijack of rival's website
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
Piper Jaffray Raises Price Target on Vascular Solutions (VASC) Following First Earnings Report Since DOJ Litigation
April 26, 2016 8:10 AM EDTPiper Jaffray reiterated an Overweight rating on Vascular Solutions (NASDAQ: VASC), and raised the price target to $45.00 (from $44.00), following the company's 1Q earnings report. VASC reported revenue of $39.4M vs. consensus of $38.5M and adjusted EPS of $0.26 vs. consensus of $0.23. This is the company's first quarterly earnings call since the not-guilty verdict of... More
